nodes	percent_of_prediction	percent_of_DWPC	metapath
Diatrizoate—Lacrimation increased—Fluorouracil—skin cancer	0.00558	0.00558	CcSEcCtD
Diatrizoate—Pain—Vismodegib—skin cancer	0.00539	0.00539	CcSEcCtD
Diatrizoate—Skin exfoliation—Temozolomide—skin cancer	0.00533	0.00533	CcSEcCtD
Diatrizoate—Injury—Bleomycin—skin cancer	0.00522	0.00522	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Imiquimod—skin cancer	0.00513	0.00513	CcSEcCtD
Diatrizoate—Myocardial infarction—Imiquimod—skin cancer	0.0051	0.0051	CcSEcCtD
Diatrizoate—Conjunctivitis—Imiquimod—skin cancer	0.00506	0.00506	CcSEcCtD
Diatrizoate—Chills—Vemurafenib—skin cancer	0.00492	0.00492	CcSEcCtD
Diatrizoate—Erythema—Vemurafenib—skin cancer	0.00477	0.00477	CcSEcCtD
Diatrizoate—Necrosis—Docetaxel—skin cancer	0.00473	0.00473	CcSEcCtD
Diatrizoate—Haemoglobin—Imiquimod—skin cancer	0.0047	0.0047	CcSEcCtD
Diatrizoate—Coma—Fluorouracil—skin cancer	0.0047	0.0047	CcSEcCtD
Diatrizoate—Rhinitis—Imiquimod—skin cancer	0.00469	0.00469	CcSEcCtD
Diatrizoate—Thrombophlebitis—Temozolomide—skin cancer	0.00468	0.00468	CcSEcCtD
Diatrizoate—Haemorrhage—Imiquimod—skin cancer	0.00467	0.00467	CcSEcCtD
Diatrizoate—Dysgeusia—Vemurafenib—skin cancer	0.00467	0.00467	CcSEcCtD
Diatrizoate—Asthenia—Vismodegib—skin cancer	0.00452	0.00452	CcSEcCtD
Diatrizoate—Pruritus—Vismodegib—skin cancer	0.00446	0.00446	CcSEcCtD
Diatrizoate—Eye irritation—Docetaxel—skin cancer	0.00434	0.00434	CcSEcCtD
Diatrizoate—Flushing—Imiquimod—skin cancer	0.00434	0.00434	CcSEcCtD
Diatrizoate—Diarrhoea—Vismodegib—skin cancer	0.00431	0.00431	CcSEcCtD
Diatrizoate—Thrombophlebitis—Fluorouracil—skin cancer	0.00431	0.00431	CcSEcCtD
Diatrizoate—Amnesia—Temozolomide—skin cancer	0.00431	0.00431	CcSEcCtD
Diatrizoate—Extravasation—Docetaxel—skin cancer	0.00425	0.00425	CcSEcCtD
Diatrizoate—Swelling—Fluorouracil—skin cancer	0.00423	0.00423	CcSEcCtD
Diatrizoate—Chills—Imiquimod—skin cancer	0.00419	0.00419	CcSEcCtD
Diatrizoate—Arrhythmia—Imiquimod—skin cancer	0.00418	0.00418	CcSEcCtD
Diatrizoate—Cough—Vemurafenib—skin cancer	0.00416	0.00416	CcSEcCtD
Diatrizoate—Bronchospasm—Bleomycin—skin cancer	0.00408	0.00408	CcSEcCtD
Diatrizoate—Erythema—Imiquimod—skin cancer	0.00407	0.00407	CcSEcCtD
Diatrizoate—Oliguria—Docetaxel—skin cancer	0.00403	0.00403	CcSEcCtD
Diatrizoate—Lacrimation increased—Docetaxel—skin cancer	0.00403	0.00403	CcSEcCtD
Diatrizoate—Vomiting—Vismodegib—skin cancer	0.00401	0.00401	CcSEcCtD
Diatrizoate—Drug interaction—Docetaxel—skin cancer	0.004	0.004	CcSEcCtD
Diatrizoate—Rash—Vismodegib—skin cancer	0.00397	0.00397	CcSEcCtD
Diatrizoate—Amnesia—Fluorouracil—skin cancer	0.00397	0.00397	CcSEcCtD
Diatrizoate—Dermatitis—Vismodegib—skin cancer	0.00397	0.00397	CcSEcCtD
Diatrizoate—Face oedema—Temozolomide—skin cancer	0.00391	0.00391	CcSEcCtD
Diatrizoate—Anaphylactic shock—Vemurafenib—skin cancer	0.00389	0.00389	CcSEcCtD
Diatrizoate—Infection—Vemurafenib—skin cancer	0.00387	0.00387	CcSEcCtD
Diatrizoate—Nausea—Vismodegib—skin cancer	0.00374	0.00374	CcSEcCtD
Diatrizoate—Agitation—Imiquimod—skin cancer	0.00374	0.00374	CcSEcCtD
Diatrizoate—Angioedema—Imiquimod—skin cancer	0.00372	0.00372	CcSEcCtD
Diatrizoate—Pulmonary embolism—Docetaxel—skin cancer	0.00371	0.00371	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Bleomycin—skin cancer	0.00365	0.00365	CcSEcCtD
Diatrizoate—Hypotension—Vemurafenib—skin cancer	0.00364	0.00364	CcSEcCtD
Diatrizoate—Myocardial infarction—Bleomycin—skin cancer	0.00363	0.00363	CcSEcCtD
Diatrizoate—Neutropenia—Dactinomycin—skin cancer	0.00362	0.00362	CcSEcCtD
Diatrizoate—Loss of consciousness—Imiquimod—skin cancer	0.00358	0.00358	CcSEcCtD
Diatrizoate—Cough—Imiquimod—skin cancer	0.00355	0.00355	CcSEcCtD
Diatrizoate—Cardiac arrest—Fluorouracil—skin cancer	0.00355	0.00355	CcSEcCtD
Diatrizoate—Skin exfoliation—Docetaxel—skin cancer	0.00354	0.00354	CcSEcCtD
Diatrizoate—Haematuria—Bleomycin—skin cancer	0.00353	0.00353	CcSEcCtD
Diatrizoate—Convulsion—Imiquimod—skin cancer	0.00353	0.00353	CcSEcCtD
Diatrizoate—Hypertension—Imiquimod—skin cancer	0.00351	0.00351	CcSEcCtD
Diatrizoate—Chest pain—Imiquimod—skin cancer	0.00346	0.00346	CcSEcCtD
Diatrizoate—Haemoglobin—Bleomycin—skin cancer	0.00334	0.00334	CcSEcCtD
Diatrizoate—Oedema—Imiquimod—skin cancer	0.00332	0.00332	CcSEcCtD
Diatrizoate—Haemorrhage—Bleomycin—skin cancer	0.00332	0.00332	CcSEcCtD
Diatrizoate—Hypoaesthesia—Bleomycin—skin cancer	0.0033	0.0033	CcSEcCtD
Diatrizoate—Pulmonary oedema—Docetaxel—skin cancer	0.0033	0.0033	CcSEcCtD
Diatrizoate—Infection—Imiquimod—skin cancer	0.0033	0.0033	CcSEcCtD
Diatrizoate—Neutropenia—Temozolomide—skin cancer	0.00327	0.00327	CcSEcCtD
Diatrizoate—Shock—Imiquimod—skin cancer	0.00327	0.00327	CcSEcCtD
Diatrizoate—Tachycardia—Imiquimod—skin cancer	0.00324	0.00324	CcSEcCtD
Diatrizoate—Hyperhidrosis—Imiquimod—skin cancer	0.00321	0.00321	CcSEcCtD
Diatrizoate—Thrombophlebitis—Docetaxel—skin cancer	0.00311	0.00311	CcSEcCtD
Diatrizoate—Flushing—Bleomycin—skin cancer	0.00308	0.00308	CcSEcCtD
Diatrizoate—Body temperature increased—Vemurafenib—skin cancer	0.00308	0.00308	CcSEcCtD
Diatrizoate—Swelling—Docetaxel—skin cancer	0.00305	0.00305	CcSEcCtD
Diatrizoate—Paraesthesia—Imiquimod—skin cancer	0.00298	0.00298	CcSEcCtD
Diatrizoate—Chills—Bleomycin—skin cancer	0.00298	0.00298	CcSEcCtD
Diatrizoate—Dyspnoea—Imiquimod—skin cancer	0.00296	0.00296	CcSEcCtD
Diatrizoate—Erythema—Bleomycin—skin cancer	0.00289	0.00289	CcSEcCtD
Diatrizoate—Flushing—Dactinomycin—skin cancer	0.00287	0.00287	CcSEcCtD
Diatrizoate—Pain—Imiquimod—skin cancer	0.00284	0.00284	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Fluorouracil—skin cancer	0.00283	0.00283	CcSEcCtD
Diatrizoate—Myocardial infarction—Fluorouracil—skin cancer	0.00282	0.00282	CcSEcCtD
Diatrizoate—Haemoglobin—Temozolomide—skin cancer	0.00282	0.00282	CcSEcCtD
Diatrizoate—Haemorrhage—Temozolomide—skin cancer	0.0028	0.0028	CcSEcCtD
Diatrizoate—Conjunctivitis—Fluorouracil—skin cancer	0.00279	0.00279	CcSEcCtD
Diatrizoate—Asthenia—Vemurafenib—skin cancer	0.00279	0.00279	CcSEcCtD
Diatrizoate—Hypoaesthesia—Temozolomide—skin cancer	0.00279	0.00279	CcSEcCtD
Diatrizoate—Chills—Dactinomycin—skin cancer	0.00278	0.00278	CcSEcCtD
Diatrizoate—Pruritus—Vemurafenib—skin cancer	0.00276	0.00276	CcSEcCtD
Diatrizoate—Feeling abnormal—Imiquimod—skin cancer	0.00274	0.00274	CcSEcCtD
Diatrizoate—Erythema—Dactinomycin—skin cancer	0.0027	0.0027	CcSEcCtD
Diatrizoate—Anaemia—Bleomycin—skin cancer	0.00267	0.00267	CcSEcCtD
Diatrizoate—Diarrhoea—Vemurafenib—skin cancer	0.00266	0.00266	CcSEcCtD
Diatrizoate—Urticaria—Imiquimod—skin cancer	0.00264	0.00264	CcSEcCtD
Diatrizoate—Body temperature increased—Imiquimod—skin cancer	0.00263	0.00263	CcSEcCtD
Diatrizoate—Flushing—Temozolomide—skin cancer	0.0026	0.0026	CcSEcCtD
Diatrizoate—Haemoglobin—Fluorouracil—skin cancer	0.00259	0.00259	CcSEcCtD
Diatrizoate—Leukopenia—Bleomycin—skin cancer	0.00259	0.00259	CcSEcCtD
Diatrizoate—Rhinitis—Fluorouracil—skin cancer	0.00259	0.00259	CcSEcCtD
Diatrizoate—Haemorrhage—Fluorouracil—skin cancer	0.00258	0.00258	CcSEcCtD
Diatrizoate—Dizziness—Vemurafenib—skin cancer	0.00258	0.00258	CcSEcCtD
Diatrizoate—Hypoaesthesia—Fluorouracil—skin cancer	0.00257	0.00257	CcSEcCtD
Diatrizoate—Cough—Bleomycin—skin cancer	0.00252	0.00252	CcSEcCtD
Diatrizoate—Chills—Temozolomide—skin cancer	0.00251	0.00251	CcSEcCtD
Diatrizoate—Anaemia—Dactinomycin—skin cancer	0.00249	0.00249	CcSEcCtD
Diatrizoate—Vomiting—Vemurafenib—skin cancer	0.00248	0.00248	CcSEcCtD
Diatrizoate—Chest pain—Bleomycin—skin cancer	0.00246	0.00246	CcSEcCtD
Diatrizoate—Rash—Vemurafenib—skin cancer	0.00246	0.00246	CcSEcCtD
Diatrizoate—Dermatitis—Vemurafenib—skin cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Headache—Vemurafenib—skin cancer	0.00244	0.00244	CcSEcCtD
Diatrizoate—Erythema—Temozolomide—skin cancer	0.00244	0.00244	CcSEcCtD
Diatrizoate—Cramp muscle—Docetaxel—skin cancer	0.00242	0.00242	CcSEcCtD
Diatrizoate—Leukopenia—Dactinomycin—skin cancer	0.00241	0.00241	CcSEcCtD
Diatrizoate—Dysgeusia—Temozolomide—skin cancer	0.00239	0.00239	CcSEcCtD
Diatrizoate—Asthenia—Imiquimod—skin cancer	0.00238	0.00238	CcSEcCtD
Diatrizoate—Confusional state—Bleomycin—skin cancer	0.00238	0.00238	CcSEcCtD
Diatrizoate—Oedema—Bleomycin—skin cancer	0.00236	0.00236	CcSEcCtD
Diatrizoate—Anaphylactic shock—Bleomycin—skin cancer	0.00236	0.00236	CcSEcCtD
Diatrizoate—Pruritus—Imiquimod—skin cancer	0.00235	0.00235	CcSEcCtD
Diatrizoate—Infection—Bleomycin—skin cancer	0.00234	0.00234	CcSEcCtD
Diatrizoate—Nausea—Vemurafenib—skin cancer	0.00231	0.00231	CcSEcCtD
Diatrizoate—Thrombocytopenia—Bleomycin—skin cancer	0.00231	0.00231	CcSEcCtD
Diatrizoate—Arrhythmia—Fluorouracil—skin cancer	0.00231	0.00231	CcSEcCtD
Diatrizoate—Bronchospasm—Docetaxel—skin cancer	0.00229	0.00229	CcSEcCtD
Diatrizoate—Tremor—Temozolomide—skin cancer	0.00228	0.00228	CcSEcCtD
Diatrizoate—Diarrhoea—Imiquimod—skin cancer	0.00227	0.00227	CcSEcCtD
Diatrizoate—Anaemia—Temozolomide—skin cancer	0.00225	0.00225	CcSEcCtD
Diatrizoate—Erythema—Fluorouracil—skin cancer	0.00225	0.00225	CcSEcCtD
Diatrizoate—Agitation—Temozolomide—skin cancer	0.00224	0.00224	CcSEcCtD
Diatrizoate—Angioedema—Temozolomide—skin cancer	0.00223	0.00223	CcSEcCtD
Diatrizoate—Hypotension—Bleomycin—skin cancer	0.0022	0.0022	CcSEcCtD
Diatrizoate—Oedema—Dactinomycin—skin cancer	0.0022	0.0022	CcSEcCtD
Diatrizoate—Dizziness—Imiquimod—skin cancer	0.0022	0.0022	CcSEcCtD
Diatrizoate—Infection—Dactinomycin—skin cancer	0.00219	0.00219	CcSEcCtD
Diatrizoate—Leukopenia—Temozolomide—skin cancer	0.00218	0.00218	CcSEcCtD
Diatrizoate—Neutropenia—Docetaxel—skin cancer	0.00218	0.00218	CcSEcCtD
Diatrizoate—Thrombocytopenia—Dactinomycin—skin cancer	0.00215	0.00215	CcSEcCtD
Diatrizoate—Cough—Temozolomide—skin cancer	0.00213	0.00213	CcSEcCtD
Diatrizoate—Paraesthesia—Bleomycin—skin cancer	0.00212	0.00212	CcSEcCtD
Diatrizoate—Convulsion—Temozolomide—skin cancer	0.00211	0.00211	CcSEcCtD
Diatrizoate—Vomiting—Imiquimod—skin cancer	0.00211	0.00211	CcSEcCtD
Diatrizoate—Hypertension—Temozolomide—skin cancer	0.00211	0.00211	CcSEcCtD
Diatrizoate—Dyspnoea—Bleomycin—skin cancer	0.0021	0.0021	CcSEcCtD
Diatrizoate—Rash—Imiquimod—skin cancer	0.00209	0.00209	CcSEcCtD
Diatrizoate—Dermatitis—Imiquimod—skin cancer	0.00209	0.00209	CcSEcCtD
Diatrizoate—Headache—Imiquimod—skin cancer	0.00208	0.00208	CcSEcCtD
Diatrizoate—Anaemia—Fluorouracil—skin cancer	0.00208	0.00208	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Docetaxel—skin cancer	0.00205	0.00205	CcSEcCtD
Diatrizoate—Renal failure—Docetaxel—skin cancer	0.00204	0.00204	CcSEcCtD
Diatrizoate—Myocardial infarction—Docetaxel—skin cancer	0.00203	0.00203	CcSEcCtD
Diatrizoate—Pain—Bleomycin—skin cancer	0.00202	0.00202	CcSEcCtD
Diatrizoate—Conjunctivitis—Docetaxel—skin cancer	0.00202	0.00202	CcSEcCtD
Diatrizoate—Leukopenia—Fluorouracil—skin cancer	0.00201	0.00201	CcSEcCtD
Diatrizoate—Confusional state—Temozolomide—skin cancer	0.00201	0.00201	CcSEcCtD
Diatrizoate—Anaphylactic shock—Temozolomide—skin cancer	0.00199	0.00199	CcSEcCtD
Diatrizoate—Oedema—Temozolomide—skin cancer	0.00199	0.00199	CcSEcCtD
Diatrizoate—Infection—Temozolomide—skin cancer	0.00198	0.00198	CcSEcCtD
Diatrizoate—Nausea—Imiquimod—skin cancer	0.00197	0.00197	CcSEcCtD
Diatrizoate—Thrombocytopenia—Temozolomide—skin cancer	0.00195	0.00195	CcSEcCtD
Diatrizoate—Convulsion—Fluorouracil—skin cancer	0.00195	0.00195	CcSEcCtD
Diatrizoate—Feeling abnormal—Bleomycin—skin cancer	0.00194	0.00194	CcSEcCtD
Diatrizoate—Hyperhidrosis—Temozolomide—skin cancer	0.00192	0.00192	CcSEcCtD
Diatrizoate—Chest pain—Fluorouracil—skin cancer	0.00191	0.00191	CcSEcCtD
Diatrizoate—Pain—Dactinomycin—skin cancer	0.00188	0.00188	CcSEcCtD
Diatrizoate—Urticaria—Bleomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Diatrizoate—Haemoglobin—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Diatrizoate—Rhinitis—Docetaxel—skin cancer	0.00187	0.00187	CcSEcCtD
Diatrizoate—Body temperature increased—Bleomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Diatrizoate—Haemorrhage—Docetaxel—skin cancer	0.00186	0.00186	CcSEcCtD
Diatrizoate—Hypoaesthesia—Docetaxel—skin cancer	0.00185	0.00185	CcSEcCtD
Diatrizoate—Confusional state—Fluorouracil—skin cancer	0.00185	0.00185	CcSEcCtD
Diatrizoate—Anaphylactic shock—Fluorouracil—skin cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Oedema—Fluorouracil—skin cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Infection—Fluorouracil—skin cancer	0.00182	0.00182	CcSEcCtD
Diatrizoate—Feeling abnormal—Dactinomycin—skin cancer	0.00181	0.00181	CcSEcCtD
Diatrizoate—Thrombocytopenia—Fluorouracil—skin cancer	0.0018	0.0018	CcSEcCtD
Diatrizoate—Tachycardia—Fluorouracil—skin cancer	0.00179	0.00179	CcSEcCtD
Diatrizoate—Paraesthesia—Temozolomide—skin cancer	0.00179	0.00179	CcSEcCtD
Diatrizoate—Dyspnoea—Temozolomide—skin cancer	0.00177	0.00177	CcSEcCtD
Diatrizoate—Body temperature increased—Dactinomycin—skin cancer	0.00174	0.00174	CcSEcCtD
Diatrizoate—Flushing—Docetaxel—skin cancer	0.00173	0.00173	CcSEcCtD
Diatrizoate—Hypotension—Fluorouracil—skin cancer	0.00171	0.00171	CcSEcCtD
Diatrizoate—Pain—Temozolomide—skin cancer	0.0017	0.0017	CcSEcCtD
Diatrizoate—Asthenia—Bleomycin—skin cancer	0.00169	0.00169	CcSEcCtD
Diatrizoate—Chills—Docetaxel—skin cancer	0.00167	0.00167	CcSEcCtD
Diatrizoate—Pruritus—Bleomycin—skin cancer	0.00167	0.00167	CcSEcCtD
Diatrizoate—Arrhythmia—Docetaxel—skin cancer	0.00166	0.00166	CcSEcCtD
Diatrizoate—Paraesthesia—Fluorouracil—skin cancer	0.00165	0.00165	CcSEcCtD
Diatrizoate—Feeling abnormal—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Diatrizoate—Dyspnoea—Fluorouracil—skin cancer	0.00163	0.00163	CcSEcCtD
Diatrizoate—Erythema—Docetaxel—skin cancer	0.00162	0.00162	CcSEcCtD
Diatrizoate—Dysgeusia—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Diatrizoate—Urticaria—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Diatrizoate—Asthenia—Dactinomycin—skin cancer	0.00158	0.00158	CcSEcCtD
Diatrizoate—Body temperature increased—Temozolomide—skin cancer	0.00157	0.00157	CcSEcCtD
Diatrizoate—Pain—Fluorouracil—skin cancer	0.00157	0.00157	CcSEcCtD
Diatrizoate—Muscle spasms—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Diatrizoate—Feeling abnormal—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Diatrizoate—Diarrhoea—Dactinomycin—skin cancer	0.00151	0.00151	CcSEcCtD
Diatrizoate—Vomiting—Bleomycin—skin cancer	0.0015	0.0015	CcSEcCtD
Diatrizoate—Anaemia—Docetaxel—skin cancer	0.0015	0.0015	CcSEcCtD
Diatrizoate—Rash—Bleomycin—skin cancer	0.00149	0.00149	CcSEcCtD
Diatrizoate—Dermatitis—Bleomycin—skin cancer	0.00149	0.00149	CcSEcCtD
Diatrizoate—Urticaria—Fluorouracil—skin cancer	0.00146	0.00146	CcSEcCtD
Diatrizoate—Leukopenia—Docetaxel—skin cancer	0.00145	0.00145	CcSEcCtD
Diatrizoate—Body temperature increased—Fluorouracil—skin cancer	0.00145	0.00145	CcSEcCtD
Diatrizoate—Asthenia—Temozolomide—skin cancer	0.00143	0.00143	CcSEcCtD
Diatrizoate—Loss of consciousness—Docetaxel—skin cancer	0.00143	0.00143	CcSEcCtD
Diatrizoate—Cough—Docetaxel—skin cancer	0.00142	0.00142	CcSEcCtD
Diatrizoate—Pruritus—Temozolomide—skin cancer	0.00141	0.00141	CcSEcCtD
Diatrizoate—Convulsion—Docetaxel—skin cancer	0.00141	0.00141	CcSEcCtD
Diatrizoate—Nausea—Bleomycin—skin cancer	0.0014	0.0014	CcSEcCtD
Diatrizoate—Hypertension—Docetaxel—skin cancer	0.0014	0.0014	CcSEcCtD
Diatrizoate—Vomiting—Dactinomycin—skin cancer	0.0014	0.0014	CcSEcCtD
Diatrizoate—Rash—Dactinomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Diatrizoate—Chest pain—Docetaxel—skin cancer	0.00138	0.00138	CcSEcCtD
Diatrizoate—Diarrhoea—Temozolomide—skin cancer	0.00136	0.00136	CcSEcCtD
Diatrizoate—Confusional state—Docetaxel—skin cancer	0.00133	0.00133	CcSEcCtD
Diatrizoate—Oedema—Docetaxel—skin cancer	0.00132	0.00132	CcSEcCtD
Diatrizoate—Anaphylactic shock—Docetaxel—skin cancer	0.00132	0.00132	CcSEcCtD
Diatrizoate—Dizziness—Temozolomide—skin cancer	0.00132	0.00132	CcSEcCtD
Diatrizoate—Infection—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
Diatrizoate—Nausea—Dactinomycin—skin cancer	0.00131	0.00131	CcSEcCtD
Diatrizoate—Shock—Docetaxel—skin cancer	0.0013	0.0013	CcSEcCtD
Diatrizoate—Pruritus—Fluorouracil—skin cancer	0.0013	0.0013	CcSEcCtD
Diatrizoate—Thrombocytopenia—Docetaxel—skin cancer	0.0013	0.0013	CcSEcCtD
Diatrizoate—Tachycardia—Docetaxel—skin cancer	0.00129	0.00129	CcSEcCtD
Diatrizoate—Vomiting—Temozolomide—skin cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Rash—Temozolomide—skin cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Diarrhoea—Fluorouracil—skin cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Dermatitis—Temozolomide—skin cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Headache—Temozolomide—skin cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Hypotension—Docetaxel—skin cancer	0.00124	0.00124	CcSEcCtD
Diatrizoate—Dizziness—Fluorouracil—skin cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Paraesthesia—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Nausea—Temozolomide—skin cancer	0.00118	0.00118	CcSEcCtD
Diatrizoate—Dyspnoea—Docetaxel—skin cancer	0.00118	0.00118	CcSEcCtD
Diatrizoate—Vomiting—Fluorouracil—skin cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Rash—Fluorouracil—skin cancer	0.00116	0.00116	CcSEcCtD
Diatrizoate—Dermatitis—Fluorouracil—skin cancer	0.00116	0.00116	CcSEcCtD
Diatrizoate—Headache—Fluorouracil—skin cancer	0.00115	0.00115	CcSEcCtD
Diatrizoate—Pain—Docetaxel—skin cancer	0.00113	0.00113	CcSEcCtD
Diatrizoate—Feeling abnormal—Docetaxel—skin cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Nausea—Fluorouracil—skin cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Body temperature increased—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Diatrizoate—Asthenia—Docetaxel—skin cancer	0.00095	0.00095	CcSEcCtD
Diatrizoate—Pruritus—Docetaxel—skin cancer	0.000936	0.000936	CcSEcCtD
Diatrizoate—Diarrhoea—Docetaxel—skin cancer	0.000906	0.000906	CcSEcCtD
Diatrizoate—Dizziness—Docetaxel—skin cancer	0.000875	0.000875	CcSEcCtD
Diatrizoate—Vomiting—Docetaxel—skin cancer	0.000842	0.000842	CcSEcCtD
Diatrizoate—Rash—Docetaxel—skin cancer	0.000835	0.000835	CcSEcCtD
Diatrizoate—Dermatitis—Docetaxel—skin cancer	0.000834	0.000834	CcSEcCtD
Diatrizoate—Headache—Docetaxel—skin cancer	0.000829	0.000829	CcSEcCtD
Diatrizoate—Nausea—Docetaxel—skin cancer	0.000786	0.000786	CcSEcCtD
